Publications by authors named "Adriano S Campos"

A mycobacterial codon-optimized gene encoding the Sm14 antigen of Schistosoma mansoni was generated using oligonucleotide assembly. This synthetic gene enhanced approximately fourfold the protein expression level in recombinant Mycobacterium bovis Bacille Calmette-Guérin (rBCG) when compared to that obtained using the native gene in the same expression vector. Immunization of mice with rBCG expressing Sm14 via the synthetic gene induced specific cellular Th1-predominant immune responses, as determined by interferon-gamma production of Sm14-stimulated splenocytes, which were comparable to those recorded in animals immunized with an rBCG strain expressing the native gene.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluated the immune responses in mice inoculated with a genetically modified strain of Mycobacterium bovis BCG that expresses the MSP1a antigen from Anaplasma marginale.
  • The results showed significant seroconversion to MSP1a in mice, particularly with the rBCG/pUS2000 construct, which was 26 times higher than pre-immunization levels after 63 days and remained sustained for 6 months.
  • The research indicates that the level of antigen expression affects the immune response, highlighting the potential of using recombinant BCG in cattle to help control bovine anaplasmosis.
View Article and Find Full Text PDF

The Sm14 antigen of Schistosoma mansoni was cloned and expressed in Mycobacterium bovis BCG as a fusion with the Mycobacterium fortuitum beta-lactamase protein under the control of its promoter, pBlaF*; the protein was localized in the bacterial cell wall. The rBCG-Sm14 strain was shown to be relatively stable in cultured murine and bovine monocytes in terms of infectivity, bacterial persistence, and plasmid stability. The immunization of mice with rBCG-Sm14 showed no induction of anti-Sm14 antibodies; however, splenocytes of immunized mice released increased levels of gamma interferon upon stimulation with recombinant Sm14 (rSm14), indicating an induction of a Th1-predominant cellular response against Sm14.

View Article and Find Full Text PDF